An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits

Biochemical and Biophysical Research Communications
W Campbell, H Okada

Abstract

An unstable carboxypeptidase N or B like enzyme is generated as a result of coagulation. This enzyme is derived from some plasma component (s) and not from blood cells or platelets. Furthermore, the activity generated is specific for arginine substrates insofar as small synthetic substrates are concerned. The enzyme is unrelated to CPN or any of its subunits or subunit fragments. This transient carboxypeptidase may be involved in the processing and/or scheduling of different functions of bioactive peptides generated during inflammation.

References

Aug 1, 1988·Trends in Pharmacological Sciences·R A Skidgel
May 30, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·D HendriksS Scharpé
Nov 15, 1973·Journal of Molecular Biology·U K Laemmli, M Favre
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·Y LevinE G Erdös
Jan 1, 1981·Methods in Enzymology·T H Plummer, E G Erdös
Jul 1, 1962·Biochemical Pharmacology·E G ERDOS, E M SLOANE

❮ Previous
Next ❯

Citations

Feb 26, 2004·Bioorganic & Medicinal Chemistry·Magnus O PollaHerb Anderson
Apr 15, 2004·Bioorganic & Medicinal Chemistry Letters·Philippe G NantermetHarold G Selnick
Dec 23, 2003·Molecular Immunology·Kirstin W MatthewsRick A Wetsel
Feb 25, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·K A SchattemanD F Hendriks
Dec 12, 2001·Toxicon : Official Journal of the International Society on Toxinology·Steven D Aird
Sep 25, 2001·Thrombosis Research·D C Rijken, D V Sakharov
Aug 26, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A ReijerkerkM F Gebbink
Feb 19, 2002·Kidney International·Hiroshi IkeguchiSeiichi Matsuo
Oct 22, 2003·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Cheng Hock Toh
May 1, 2004·Critical Care Medicine·Laszlo BajzarJohn B Walker
Jul 8, 1998·Microbiology and Immunology·M WatanabeH Okada
Oct 21, 1999·Microbiology and Immunology·X GuoH Okada
Mar 11, 2000·Microbiology and Immunology·X GuoH Okada
Apr 10, 2002·Microbiology and Immunology·Hidefumi KomuraHidechika Okada
Apr 10, 2002·Microbiology and Immunology·William D CampbellHidechika Okada
May 15, 2002·Microbiology and Immunology·Hidefumi KomuraHidechika Okada
May 15, 2002·Microbiology and Immunology·Takeshi KawamuraHidechika Okada
Feb 5, 2005·Pathophysiology of Haemostasis and Thrombosis·Bonno N Bouma, Laurent O Mosnier
Jan 10, 2002·The Journal of Clinical Investigation·Mariko NagashimaJohn Morser
Nov 6, 2002·The Journal of Clinical Investigation·Carmen M SwaisgoodEdward F Plow
Nov 16, 2006·Blood·Toshihiko NishimuraLawrence L K Leung
Jul 8, 2010·Biological & Pharmaceutical Bulletin·Suzuka AsaiNoriko Okada
Jun 2, 2011·Hämostaseologie·P J Declerck
Mar 31, 2016·Journal of Thrombosis and Haemostasis : JTH·J H FoleyUNKNOWN Subcommittee on Fibrinolysis
Nov 19, 2015·Microbiology and Immunology·Eszter TubolyHidechika Okada
Sep 13, 2003·Chest·Michael Nesheim
Jan 30, 2007·Hematology/oncology Clinics of North America·Lisa Payne Rojkjaer, Rasmus Rojkjaer
Dec 23, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Luci Maria SantAna DusseBashir A Lwaleed
Oct 1, 2005·Journal of Thrombosis and Haemostasis : JTH·M Nesheim, L Bajzar
Jun 13, 2003·Microbiology and Immunology·Sayuri TaniHidechika Okada
Jun 27, 2007·British Journal of Haematology·Mathieu GarandMarlys L Koschinsky
Nov 20, 2008·Journal of Thrombosis and Haemostasis : JTH·D C Rijken, H R Lijnen
Jul 17, 2013·Journal of Thrombosis and Haemostasis : JTH·J H FoleyA Gils
May 3, 2003·Microbiology and Immunology·Yasuyo ShimomuraHidechika Okada
Nov 4, 2004·British Journal of Haematology·Hiroyasu AkatsuHidechika Okada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie
D HendriksM P Lommaert
International Archives of Allergy and Immunology
T ShinoharaH Okada
© 2022 Meta ULC. All rights reserved